Genetic polymorphisms associated with treatment failure and mortality in pediatric Pneumocystosis

15Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

C) and DHPS 96/98 were frequently observed and clinically associated with severe PCP and treatment failure. Phylogenetic analyses revealed 13 unique sequence types (STs). Two STs (i) 3-DHFR 401 T > C-DHPS 96/98 – PJ1 and (ii) 3-DHFR 401 T > C-DHPS 96- PJ3 were significantly associated with treatment failure and high mortality among PCP-positive patients. In conclusion, the present study strongly suggests the emergence of virulent P. jirovecii strains or genetic polymorphisms, leading to treatment failure and high mortality. Our study is the first of its kind from the Indian subcontinent and has highlighted the genetic diversity of Pneumocystis jirovecii among children and their clinical outcomes. These findings emphasize the need to focus more on genotypes to better understand the epidemiology of Pneumocystis pneumonia.

Cite

CITATION STYLE

APA

Singh, Y., Mirdha, B. R., Guleria, R., Kabra, S. K., Mohan, A., Chaudhry, R., … Agarwal, S. K. (2019). Genetic polymorphisms associated with treatment failure and mortality in pediatric Pneumocystosis. Scientific Reports, 9(1). https://doi.org/10.1038/s41598-018-38052-x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free